|Articles|November 1, 2004
Acne by gender: It surfaces sooner, stays longer in females
For more acne coverage, see our special supplement with this issue.
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.